Tackling the toughest drug discovery challenges through expertise
Talem boasts 30 years of hands-on experience in antibody discovery and development, offering you a unique advantage in generating clinically-ready antibody programs for successful market entry.
On a mission to advance
Taking aim at research and development innovation for novel therapeutics
At Talem, we envision a healthier world powered by cutting-edge science and innovation. Our mission is to advance novel therapeutics for high-value targets and high-priority diseases. By forging strategic partnerships and harnessing a transformative next-gen vault of antibody assets, we are committed to the delivery of tomorrows innovation.
Engineered for the clinical race
Focused on advancing novel therapeutics for high-value targets and high-priority diseases
Leveraging over 30 years of innovative science and drug development experience
Dedicated to advancing and delivering
With direct access to world-class, expedited and end-to-end technologies in antibody discovery, characterization, manufacturing and engineering, Talem accelerates development of novel, antibody therapeutics through strategic alliances and partnerships..
Are you an interested investor?
Visit our IPA investor relations site for background, financial reports, and news